Gvanklofin je antagonist beta adrenergičkog receptora.[3]

Gvanklofin
Nazivi
IUPAC naziv
2-[2-(2,6-dihloroanilino)etil]gvanidin
Drugi nazivi
(2-(2,6-dihloroanilino)etil)gvanidin
Identifikacija
3D model (Jmol)
UNII
  • C1=CC(=C(C(=C1)Cl)NCCN=C(N)N)Cl
Svojstva
C9H12Cl2N4
Molarna masa 247,12 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Reference

уреди
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ E Glusa; F Markwardt; B Förster (1982). „Effect of guanclofin on catecholamine release by the adrenal medulla”. Farmakol Toksikol. 45 (4): 27—30.